HSA 召回 Decondine Syrup 新加坡所有在效期内批次
Recall of Decondine Syrup
HSA 宣布召回 Sunward Pharmaceutical Pte Ltd 的 Decondine Syrup（注册号 SIN03181P），原因是稳定性批次中曲普利啶含量、pH 与黏度检验结果不符合标准，新加坡所有在效期内批次作为预防措施被召回，涉批次 307-24001、307-24006、307-24007、307-24021 和 307-25004。
材料列出五个受影响批次、2级零售层召回及稳定性检验结果不符合标准的原因，可用于核对在效期批次的停供与退货安排。
Date of recall: | 14 July 2026 |
Product: | Decondine Syrup |
Active Ingredient: | Pseudoephedrine 30mg/5ml and Triprolidine 1.25mg/5ml |
Product Category: | Therapeutic Product |
Registration Number: | SIN03181P |
Batch No.: |
|
Class of Recall: | 2 |
Level of Recall: | Retail |
Local Company: | Sunward Pharmaceutical Pte Ltd |
Description of Issue: | Out-of-specification results for triprolidine assay, pH and viscosity were observed in stability batches. As a precautionary measure, all batches currently within their expiry date in Singapore are being recalled. |
Recall Instructions: | Hospitals, clinics, pharmacies: Stop supplying the affected batch and return the remaining stocks to the company. |
来源：HSA 治疗药品召回 · hsa.gov.sg